Shikonin directly downregulates the expression of PFKFB2 in human lung cancer cells (A549 and H446), inhibiting the Warburg Effect and exerting anticancer action in lung cancer cells (Sha et al., 2021). The gene discussed is PFKFB2; the disease is lung carcinoma.